Search
Biodexa Pharmaceuticals PLC
BDRXAdd to Watchlist
2.940USD
-0.060-2.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.33MMarket Cap
16.87P/E TTM
Biodexa Pharmaceuticals PLC Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-80.84
98.89%
Analyst Rating
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its current assets were 16.49M, with a year-on-year change of 43.14.
What are the total assets of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its total assets of Biodexa Pharmaceuticals PLC were 24.10M, with a year-on-year change of 24.65.
What are the total liabilities of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its total liabilities of Biodexa Pharmaceuticals PLC were 8.98M, with a year-on-year change of 6.30.
What is the total equity of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its total equity of Biodexa Pharmaceuticals PLC was 8.60M, with a year-on-year change of -20.96.
What is the net investment of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its net investment of Biodexa Pharmaceuticals PLC was -507.69K, with a year-on-year change of 49.85.
What is the net financing of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its net financing of Biodexa Pharmaceuticals PLC was 9.85M, with a year-on-year change of -12.02.
What is the Earnings Per Share (EPS) of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -80.84, with a year-on-year change of 98.89.
What is the Return on Equity (ROE) of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its Return on Equity (ROE) was -64.72, with a year-on-year change of 26.57.
What is the Return on Assets (ROA) of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its Return on Assets (ROA) was -38.74, with a year-on-year change of 14.39.
What is the operating profit of Biodexa Pharmaceuticals PLC?
According to Biodexa Pharmaceuticals PLC's FY2025 earnings report, its operating profit was -11.46M, with a year-on-year change of 4.76.